Encarta

Telerehabilitation Systems Market to grow by USD 604.01 million from 2022 to 2027 | The increasing incidence of chronic diseases drives the market -Technavio

Retrieved on: 
Tuesday, August 22, 2023
Exercise, COPD, Honeywell, Telerehabilitation, Prevalence, Cancer, Quality of life, Rehabilitation, Cisco, Incidence, DIH, Encarta, Patient, Conditional sentence, Growth, Retail

Technavio report analyzes the market's competitive landscape and offers information on several market vendors, including BRONTES PROCESSING Sp.

Key Points: 
  • Technavio report analyzes the market's competitive landscape and offers information on several market vendors, including BRONTES PROCESSING Sp.
  • The increasing incidence of chronic diseases is notably driving the market growth.
  • The surge in chronic diseases like cancer, COPD, and autoimmune disorders is primarily attributed to the adoption of sedentary lifestyles.
  • Complexities in the implementation of Internet connection are the main challenge for the growth of the telerehabilitation systems market.

Babylon In Discussions of New Strategic Alternatives for its Businesses

Retrieved on: 
Monday, August 7, 2023
Mobile, Wireless, Technology, Finance, Health Technology, Telemedicine, Virtual Medicine, Professional Services, Software, Other Health, Health, Artificial Intelligence, OTC Markets Group, Chapter Seven, Sale, Wind, Encarta, Patient, Physician, Albacore, Security (finance)

Following Babylon’s receipt of funding under its amended bridge notes facility with AlbaCore, Babylon has no binding commitment for additional financing to continue its business operations.

Key Points: 
  • Following Babylon’s receipt of funding under its amended bridge notes facility with AlbaCore, Babylon has no binding commitment for additional financing to continue its business operations.
  • As a result, the Group is exploring new strategic alternatives in order to find the best possible outcome for its UK business.
  • In order to explore these opportunities for a Third Party Sale and enable business continuity, Babylon is in discussions with potential strategic partners to secure additional funding.
  • Babylon cannot provide assurance that it will be able to secure sufficient liquidity to fund the operations of the Group’s businesses.

Babylon Proceeds With Previously Announced Transaction and Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

Retrieved on: 
Wednesday, June 28, 2023
Mobile, Wireless, Technology, Finance, Health Technology, Telemedicine, Virtual Medicine, Professional Services, Software, Other Health, Health, Artificial Intelligence, NYSE Listed Company Manual, Electric Bond and Share Company v. Securities and Exchange Commission, Encarta, Documentation, Notice, Transaction, Albacore, NYSE, Security (finance), Cryptocurrency

The closing of the Proposed Transaction is expected in July 2023 and is subject to agreed documentation, various conditions and appropriate approvals, if required.

Key Points: 
  • The closing of the Proposed Transaction is expected in July 2023 and is subject to agreed documentation, various conditions and appropriate approvals, if required.
  • In light of the expected closing of the Proposed Transaction in July 2023, the Company does not intend to undertake actions to cure the deficiencies described above and return to compliance with the NYSE continued listing standards, and has notified the NYSE of this decision.
  • In addition, the Company expects the NYSE to subsequently delist the Class A ordinary shares from the NYSE in accordance with its procedures.
  • The Company will continue to comply with applicable Securities and Exchange Commission (“SEC”) reporting requirements.

Babylon Announces Update on Take Private Proposal

Retrieved on: 
Friday, June 23, 2023
Mobile, Wireless, Technology, Finance, Health Technology, Telemedicine, Virtual Medicine, Professional Services, Software, Other Health, Health, Artificial Intelligence, Organization, Growth, Encarta, Documentation, Albacore, NYSE

After a thorough exploration of strategic alternatives, Babylon Holdings Limited (NYSE: BBLN) (including its subsidiaries, “Babylon”) is pleased to provide an update on the recapitalization transaction, previously announced on May 10, following receipt of a proposal from AlbaCore Capital LLP on behalf of certain of its affiliates (“AlbaCore”) and MindMaze Group SA (“MindMaze”), and share that Babylon has selected the previously announced take private proposal from the options considered.

Key Points: 
  • After a thorough exploration of strategic alternatives, Babylon Holdings Limited (NYSE: BBLN) (including its subsidiaries, “Babylon”) is pleased to provide an update on the recapitalization transaction, previously announced on May 10, following receipt of a proposal from AlbaCore Capital LLP on behalf of certain of its affiliates (“AlbaCore”) and MindMaze Group SA (“MindMaze”), and share that Babylon has selected the previously announced take private proposal from the options considered.
  • The proposal strongly positions Babylon to accelerate its core mission – to make high quality healthcare more accessible and affordable by combining the most cutting-edge technology with the best medical expertise.
  • As previously stated, the transaction will not provide for any payment to Babylon Holdings Limited’s Class A ordinary shareholders or other equity instrument holders, as AlbaCore will be exercising rights under its debt agreements with Babylon, and the go-forward private business will be transferred to private ownership.
  • Therefore, the transaction would transfer core operating subsidiaries of Babylon to MindMaze, and Babylon Holdings Limited’s Class A ordinary shares will cease trading on the NYSE under the ticker symbol ‘BBLN’.

Metaverse in Healthcare Market worth $79.6 billion | MarketsandMarkets

Retrieved on: 
Tuesday, May 9, 2023
Metaverse, EON, Insurance, Medicine, GE HealthCare, VR, Internet, Hospital, Investment, Patient, Collaborative RESearch Team to study psychosocial issues in Bipolar Disorder, Meta Platforms, Software, Research, EON Reality, Organization, Application, Patient safety, Knowledge, Growth, Empowerment, AR, Learning, Blockchain, Nvidia Omniverse, Patient satisfaction, Nvidia, GE, ID, Encarta, Virtual reality, Intuitive Surgical, Near-infrared vein finder, DICE, CAE Inc., Education, Medtronic, Artificial intelligence, CMR Surgical, Health care, Pet industry, Nursing, Video game, Pharmaceutical industry, Microsoft, Oculus, Wipro

In 2022, the software segment accounted for the largest market share in metaverse in healthcare market.

Key Points: 
  • In 2022, the software segment accounted for the largest market share in metaverse in healthcare market.
  • The augmented and virtual reality segment accounted for the largest share of 28.2% of the metaverse in healthcare market in 2022.
  • By End User, the healthcare providers segment accounted for the largest share in the metaverse in healthcare market.
  • Metaverse in Healthcare Market Advantages:
    Enhanced Access to Healthcare Services: The metaverse allows for virtual consultations, enabling patients to access healthcare services remotely.

Metaverse in Healthcare Market worth $79.6 billion | MarketsandMarkets

Retrieved on: 
Tuesday, May 9, 2023
Metaverse, EON, Insurance, Medicine, GE HealthCare, VR, Internet, Hospital, Investment, Patient, Collaborative RESearch Team to study psychosocial issues in Bipolar Disorder, Meta Platforms, Software, Research, EON Reality, Organization, Application, Patient safety, Knowledge, Growth, Empowerment, AR, Learning, Blockchain, Nvidia Omniverse, Patient satisfaction, Nvidia, GE, ID, Encarta, Virtual reality, Intuitive Surgical, Near-infrared vein finder, DICE, CAE Inc., Education, Medtronic, Artificial intelligence, CMR Surgical, Health care, Pet industry, Nursing, Video game, Pharmaceutical industry, Microsoft, Oculus, Wipro

In 2022, the software segment accounted for the largest market share in metaverse in healthcare market.

Key Points: 
  • In 2022, the software segment accounted for the largest market share in metaverse in healthcare market.
  • The augmented and virtual reality segment accounted for the largest share of 28.2% of the metaverse in healthcare market in 2022.
  • By End User, the healthcare providers segment accounted for the largest share in the metaverse in healthcare market.
  • Metaverse in Healthcare Market Advantages:
    Enhanced Access to Healthcare Services: The metaverse allows for virtual consultations, enabling patients to access healthcare services remotely.

MindMaze Drives Future of Upper-Limb Neural Recovery with a First-in-Class Smart Peripheral for Hand Dexterity Assessment and Training

Retrieved on: 
Tuesday, February 14, 2023
Technology, Medical Devices, Neurology, Health Technology, Software, Biotechnology, Physical Therapy, Health, Artificial Intelligence, Encarta, Life, Berit, Hand, University College London, Stroke, United Kingdom, Hope, Wrist, TBI, Maintenance, Patient, University, DSM-IV codes, Survivor, Paralysis, Traumatic brain injury, FDA, Eating, Multimedia, Quality of life, European, Pharmaceutical industry, Nursing, EU

Not surprisingly, patients rate hand recovery as one of the most important factors associated with their improved quality of life and independence.

Key Points: 
  • Not surprisingly, patients rate hand recovery as one of the most important factors associated with their improved quality of life and independence.
  • Izar can detect sub-newton level patient finger and hand forces, enabling treatment in the most impaired patient populations.
  • Future software content will unlock training content for wrist, bilateral movements, combination movements of the upper-limb and hand, as well as dexterity assessments for hand and wrist.
  • 1Izar is a trademark of MindMaze Group SA, registered in the European Union and in Switzerland.

Eventbrite Welcomes Ted Dworkin as Chief Product Officer

Retrieved on: 
Monday, January 23, 2023
Technology, Marketing, Events, Concerts, Entertainment, Communications, Social Media, Other Technology, Digital Marketing, Apps, Applications, Software, Internet, Product management, Dworkin, Science, Yoga, NYSE, Microsoft, Senior, Foodie, Encarta, Great Places, Customer experience, EB, Love, Management, Eventbrite, Sonos

Eventbrite (NYSE: EB), a global self-service ticketing, marketing, and experience technology platform, today announced it has hired Ted Dworkin as Chief Product Officer.

Key Points: 
  • Eventbrite (NYSE: EB), a global self-service ticketing, marketing, and experience technology platform, today announced it has hired Ted Dworkin as Chief Product Officer.
  • Dworkin joins Eventbrite from Sonos where he was the Senior Vice President of Product Management and Customer Experience.
  • “I’m thrilled to welcome Ted to Eventbrite.
  • I’m so excited to be joining the talented leadership team at Eventbrite,” said Ted Dworkin.

MindMaze and Vibra Healthcare Partner to Deliver Advanced Digital Medicine and Neurorehabilitation Solutions for Patients from Clinic-to-Home

Retrieved on: 
Wednesday, December 7, 2022
Technology, Hospitals, Neurology, Health Technology, Telemedicine, Virtual Medicine, Software, Biotechnology, Managed Care, Health, Artificial Intelligence, Disease, Conditional sentence, Annals of Neurology, Partnership, Stroke, Patient, Labs, Disability, Neurology, SCI, Parkinson's disease, Health care, Transitional care, Artificial intelligence, Engineering, Neuroscience, Encarta, Acquisition, Hospital, Pharmaceutical industry, AI, Vibra Healthcare

The partnership will facilitate a large-scale roll-out of MindMaze solutions to improve care across in-patient, post-acute, community sub-acute and home-based care environments.

Key Points: 
  • The partnership will facilitate a large-scale roll-out of MindMaze solutions to improve care across in-patient, post-acute, community sub-acute and home-based care environments.
  • The need for solutions that deliver superior outcomesas well as those that support patients during the lifetime of their chronic conditionhas never been greater.
  • Founded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery.
  • For additional information about Vibra Healthcares network of specialty hospitals and post-acute care continuum, please visit its website at www.vibrahealthcare.com .

MindMaze Partners with Mount Sinai Health System to Pioneer a Digital Neurotherapeutic Program to Improve Patient Outcomes in the Clinic and at Home

Retrieved on: 
Tuesday, November 8, 2022
Neurology, Software, Hardware, Health, Artificial Intelligence, Hospitals, Health Technology, Technology, U.S. News & World Report, Neuroscience, Brain, School, Program, National, Stroke, Health, Mount Sinai Hospital (Manhattan), National Institutes of Health, Journal of Neurology, Neurosurgery, and Psychiatry, Solution, Rehabilitation, Informatics, Encarta, Community, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, U.S. News & World Report Best Hospitals Rankings, Disability, Hospital, Partnership, Mount Sinai Health System, Concussion, Health system, Technology, Engineering, Artificial intelligence, Annals of Neurology, Knowledge, News, Physician, Neurology, Patient, No, Nursing, Survivor, Mount Sinai Kravis Children's Hospital, Disease, Urology, Research, Pharmaceutical industry, Geriatrics, Newsweek, Medicine, Ophthalmology, Orthopedic surgery

MindMaze develops digital neurotherapeutic solutions designed to elevate outcome expectations today and to accelerate the future of cognitive recovery and care.

Key Points: 
  • MindMaze develops digital neurotherapeutic solutions designed to elevate outcome expectations today and to accelerate the future of cognitive recovery and care.
  • Data from the program will inform the Mount Sinai medical registry, with results supporting clinical effectiveness, scalability, and viability of the initiative.
  • MindMaze and Mount Sinai are passionate about providing stroke survivors with ever improving access to care and re-defining the possibilities with neuro-recovery.
  • Founded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery.